Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03934697 · ClinicalTrials.gov registry record · NA
Imaginal Exposure II Study: In-Vivo
A NA study, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT03934697 is a NA study that has completed, run by University of Louisville. The registered enrollment target is 43 participants.
The verdict
NCT03934697, a NA study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
The purpose of this study is to test if imaginal exposure therapy can decrease symptoms of eating disorders and anxiety.
Interventions
- BEHAVIORAL imaginal exposure therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2022-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03934697
The ClinicalTrials.gov registry entry for NCT03934697 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which imaginal exposure therapy is the first listed.
NCT03934697 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03934697 about?
NCT03934697 is a clinical study titled "Imaginal Exposure II Study: In-Vivo". The purpose of this study is to test if imaginal exposure therapy can decrease symptoms of eating disorders and anxiety.
What is the current status of trial NCT03934697?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2017-05-01. Estimated completion is 2022-10-01.
What interventions are being tested in trial NCT03934697?
The interventions under investigation include: imaginal exposure therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03934697?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.